Maximize Market Research

PUNE – – October 13, 2026 -- The global robotics market will grow from USD 92 billion in 2025 to USD 480.1 billion by 2034, a compound annual growth rate of 20.15% over 2026–2034, according to a new analysis by Maximize Market Research.

The firm attributes the expansion to industrial automation, adoption of AI-powered robots, advances in smart manufacturing and rising demand from automotive, electronics, healthcare and logistics. Demand spans industrial robots, collaborative robots (cobots), autonomous mobile robots (AMRs), automated guided vehicles (AGVs), service robots and humanoid robots. The report covers 154 data tables across 327 pages.

Pune – September 29, 2026 -- The global ethylene oxide market reached USD 62.95 billion in 2025 and is forecast to grow at a 4.59% CAGR through 2034, hitting USD 94.28 billion, according to a new report from Maximize Market Research.

Asia-Pacific dominates production and consumption, led by China, India, Japan and South Korea

The region's scale in petrochemical manufacturing, PET resin output and polyester fiber production has made it the largest ethylene oxide market as of 2025. Continued capital deployment into petrochemical facilities, healthcare infrastructure and industrial manufacturing is expected to sustain the region's lead through the forecast period.

Pune, India – September 29, 2026 -- The global glycolic acid market is projected to grow from USD 723.75 billion in 2025 to USD 1,267.06 billion by 2034, expanding at a compound annual growth rate of 6.42%, according to a new report from Maximize Market Research.

North America dominates demand as dermatology and pharmaceutical use expand

North America leads the global market, driven by strong uptake of glycolic acid in skincare, cosmetics, dermatology, and pharmaceutical formulations. The U.S. remains the largest consumer market as chemical peels, anti-aging creams, exfoliating serums, and acne treatments built on alpha hydroxy acid (AHA) chemistry gain wider adoption. The U.S. FDA identifies glycolic acid as one of the most common AHAs used in cosmetic products for exfoliation and pH adjustment.

Pune, India – September 26, 2026 -- The global dietary supplements market was valued at USD 186.36 billion in 2025 and is forecast to reach USD 324.88 billion by 2034, expanding at a compound annual growth rate of 6.37% between 2026 and 2034, according to a new report from Maximize Market Research.

North America dominates supplement demand on preventive healthcare spending

North America leads the global market, driven by high consumer spending on health and wellness, strong preventive healthcare awareness, and regulatory clarity that supports major dietary supplement manufacturers. The United States remains the largest contributor within the region, with strong uptake of vitamins, minerals, herbal supplements, probiotics, and sports nutrition products.

Pune – September 25, 2026 -- The global autoimmune treatment market reached USD 176.6 billion in 2025 and is forecast to expand at a 6.9% CAGR through 2034, hitting USD 321.95 billion, according to a new analysis from Maximize Market Research.

North America dominates the market on strong pharmaceutical R&D infrastructure

North America held the largest share of the market in 2025, driven by high disease prevalence, advanced healthcare infrastructure, established specialist care and elevated healthcare spending. The United States anchors regional growth, backed by leading pharmaceutical and biotechnology firms, advanced diagnostic capacity, and rising adoption of biologics, immunosuppressants, monoclonal antibodies and targeted therapies. Canada and Mexico are contributing through improving healthcare access and disease awareness.

Pune, India – September 25, 2026 -- The global nanomedicine market reached USD 207.91 billion in 2025 and is projected to hit USD 581.2 billion by 2034, expanding at a 12.1% compound annual growth rate, according to a new report from Maximize Market Research.

North America commands the largest share on pharmaceutical R&D strength

North America held the largest share of the market in 2025, driven by advanced healthcare infrastructure, deep pharmaceutical and biotechnology research pipelines, and high healthcare expenditure. The United States anchors regional growth through its established research ecosystem and rising adoption of nanotechnology-based drug delivery, diagnostics and precision medicine platforms. Canada and Mexico are contributing through expanding healthcare capabilities and research initiatives.

Pune, India – September 25, 2026 -- The global multiple sclerosis treatment market reached USD 26.76 billion in 2025 and is forecast to climb to USD 44.45 billion by 2034, expanding at a 5.8% CAGR, according to a new report from Maximize Market Research.

Disease-modifying therapies and biologics drive current market expansion

Rising MS prevalence, improved diagnostic capabilities, and growing adoption of immunomodulators, immunosuppressants, interferons, oral disease-modifying therapies (DMTs), and monoclonal antibodies are fueling demand across relapsing-remitting (RRMS), primary progressive (PPMS), secondary progressive (SPMS), and clinically isolated syndrome (CIS) patient segments. High-efficacy biologics and oral treatment options are increasingly displacing older therapy classes as patients and physicians prioritize convenience and disease-progression control.

Pune – September 25, 2026 -- The global bioinformatics market is projected to expand from $20.34 billion in 2025 to $64.60 billion by 2034, a 13.7% compound annual growth rate, according to new analysis from Maximize Market Research.

Genomic data volumes and NGS adoption fuel core demand

Rising volumes of genomic and biological data, driven by expanding next-generation sequencing (NGS) adoption, are pushing pharmaceutical and biotechnology companies toward advanced bioinformatics platforms, sequencing data analysis tools, and biological databases. Declining sequencing costs are drawing smaller research institutions into the market, while growing precision medicine applications are increasing demand for pharmacogenomics, biomarker analysis, and genomic diagnostics.